TRANSLATIONAL BLUEPRINTS

Proven clinical-to-market pathways.

A portfolio of deep-tech medical devices, diagnostic hardware, and clinical software architectures engineered for regulatory approval and scalable manufacturing.

SELECTED PORTFOLIO

Translating science into scale

Rigorous engineering meets commercial strategy. These case studies demonstrate how complex physiological data and hardware constraints are resolved into market-ready medical breakthroughs.

01 / HARDWARE ARCHITECTURE
02 / TRANSLATIONAL STRATEGY

Neonatal EEG Monitor

Oncology Screening Chip

Optimized a high-density clinical EEG prototype for high-volume manufacturing, reducing assembly complexity by 40% while maintaining signal integrity under stringent regulatory testing.

Developed the commercialization roadmap and clinical trial protocols for an oncology screening chip, securing $12M in Series A funding through technical risk mitigation.

Key metrics: Class II FDA Clearance • 40% assembly reduction

Key metrics: $12M Series A secured • 18-month trial roadmap

Ready to commercialize your technology?

Let's align your clinical science with a viable, venture-scale product roadmap that navigates regulatory pathways and scales efficiently.